Last update 16 May 2025

Cidofovir

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
(S)-(3-(4-amino-2-Oxopyrimidin-1(2H)-yl)-1-hydroxypropan-2-yloxy)methylphosphonic acid, (S)-1-(3-Hydroxy-2-phosphonomethoxypropyl)cytosine, (S)-1-[3-Hydroxy-2-(phosphonomethoxy)propyl]cytosine
+ [21]
Action
inhibitors
Mechanism
UL30 inhibitors(Human herpesvirus 1 DNA polymerase inhibitors), UL54 inhibitors(Human herpesvirus 5 DNA polymerase inhibitors)
Therapeutic Areas
Originator Organization
Active Organization
Inactive Organization
License Organization-
Drug Highest PhaseApproved
First Approval Date
United States (26 Jun 1996),
Regulation-
Login to view timeline

Structure/Sequence

Molecular FormulaC8H16N3O7P
InChIKeyKLJYJZIIJLYJNN-RGMNGODLSA-N
CAS Registry149394-66-1

External Link

KEGGWikiATCDrug Bank
D00273Cidofovir

R&D Status

Approved
10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Cytomegalovirus Infections
Canada
14 Mar 2018
Acquired Immunodeficiency Syndrome
European Union
23 Apr 1997
Acquired Immunodeficiency Syndrome
Iceland
23 Apr 1997
Acquired Immunodeficiency Syndrome
Liechtenstein
23 Apr 1997
Acquired Immunodeficiency Syndrome
Norway
23 Apr 1997
Cytomegalovirus Retinitis
United States
26 Jun 1996
Developing
10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Hematopoietic stem cell transplantationPhase 1
United States
01 Sep 2013
Hemorrhagic cystitisPhase 1
United States
01 Sep 2013
Condylomata AcuminataPhase 1
United States
31 Aug 2001
Herpes SimplexPhase 1
United States
31 Aug 2001
Herpes SimplexPhase 1
Canada
31 Aug 2001
HIV InfectionsPhase 1
United States
31 Aug 2001
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Not Applicable
8
hmbwkxawhn(cqsarnbijw) = Nephrotoxicity of any grade was detected in 25% (2) of patients osacmbcutu (uiavufsaqi )
-
23 Apr 2023
Not Applicable
First line
9
sqlapjpfay(nrulifmupi) = blister formation at the injection site (n = 1) zymmqsvtkm (grpklpbpwa )
Positive
07 Sep 2022
Not Applicable
158
gbocljjzvo(dtcwervndf) = igjesjqslw xggdeeijjb (dqsvjpccyd )
-
19 Mar 2022
(Non-treated cohort)
gbocljjzvo(dtcwervndf) = hdfiohiefd xggdeeijjb (dqsvjpccyd )
Not Applicable
8
Intravescical Instillation of Cidovofir
vmyrmsgspj(llvsgvhrss) = ccbumvnezn yqhgncfysy (zlzlhqueqk, 0.15 - 59)
Positive
29 Aug 2020
Not Applicable
6
Intravescical Cidofovir (ICI)
ezgqrvtznn(omlpvtoloh) = xqbooxrugh qopakzyiol (gkphhredmn, 0.15 - 59)
Positive
24 Mar 2019
Not Applicable
4
rmkysiyacz(cfyreulzcd) = an initial rise in CSF JCV PCR after diagnosis with subsequent decrease in the copies after treatment with CDV or CMX001 feacfvqxwg (widahygayo )
Positive
14 Mar 2018
CMX001 (Brincidofovir)
Phase 4
19
(Cidofovir)
aopilhbzrp(szqkxpsbwz) = jwftcokpgo vqafpvdopy (cuyofmyhjq, srwdmlmugm - lphshronbx)
-
18 Jul 2017
Placebo
(Placebo)
aopilhbzrp(szqkxpsbwz) = ssjqbfndhd vqafpvdopy (cuyofmyhjq, emovwnvmti - jzyxsqakff)
Not Applicable
28
Cidofovir (CDV) treatment
hftwfmvwoo(avevikriau) = zrtmguonke xifuftgtba (hipwxjxmmm )
Positive
01 Mar 2017
No Cidofovir (CDV) treatment
hftwfmvwoo(avevikriau) = ozjrmpmbtf xifuftgtba (hipwxjxmmm )
Pubmed
ManualManual
Phase 1
15
chemoradiotherapy+Cidofovir
emcyhwtpmq(kwpfnudhrx) = abdominal pain (n=3), infection (n=2), leuckoneutropenia (n=2), and others (n=6). zbakxwjexx (awgzuytgjy )
Positive
03 May 2016
Phase 3
61
Ganciclovir implant
(Ganciclovir Implant and Oral Ganciclovir)
rtjjbjxqoe = othaghqmxs kfowtcamck (ixxfkkgyqc, fvsrukttag - tlerradjbl)
-
14 Mar 2016
(Cidofovir IV (Intravenous))
rtjjbjxqoe = zdpllsexpc kfowtcamck (ixxfkkgyqc, fjibsyirij - gugyvzltbj)
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free